Abeta Peptide and Alzheimer's Disease

By Colin J. Barrow and David H. Small

Recent advances in genetics and brain biochemistry point to the Abeta peptide as the major culprit in causing neurodegeneration in Alzheimer's Disease (AD). This title is specifically targeted at summarizing current knowledge of the Abeta peptide and its role in AD. Written by leaders in the industrial and academic world specializing in this rapidly moving area, the book covers fundamental biochemical studies on this peptide, the genetic impact on Abeta expression and processing, and various AD therapeutic strategies that target Abeta. Although specifically focusing on the Abeta peptide and AD, there is also some discussion on the similarity and differences of this peptide and AD with other amyloidogenic diseases, such as prion disease, Parkinsons and Huntingtons. This book will primarily be of interest to AD researchers and clinicians but also to researchers of other amyloid diseases.

• Format: Paperback
• Language: English
• ISBN: 144716234X
• ISBN13: 9781447162346
• Release Date: September 2014
• Publisher: Springer
• Length: 298 Pages
• Weight: 1.55 lbs.
• Dimensions: 0.7" x 8.3" x 11.0"